Therapeutics

Browse venture capital firms focused on Therapeutics.

Explore VC firms that invest in Therapeutics. Filter by country and stage to refine results.

17 of 1000 firms
Filters:
AbbVie Ventures favicon
AbbVie Ventures
United States

The corporate venture arm of AbbVie, investing in novel, transformational therapeutics at discovery and preclinical stages.

Founded 2009
Investment Stages
Pre-Seed
Seed
Markets
Life Science & Therapeutics
Altitude Life Science Ventures favicon
Altitude Life Science Ventures
United States

Altitude Life Science Ventures is a venture capital firm investing in early-stage life science companies. They focus on markets with strong demand and growth potential, and then back the highest-quality entrepreneurs.

Founded 2006
Investment Stages
Series A
Series B
Markets
Therapeutics
Diagnostics
Gene Editing
AI
Biotechnology
Life Science
Boehringer Ingelheim Venture Fund favicon
Boehringer Ingelheim Venture Fund
Germany, United States, China

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation. It invests in pioneering science with the potential for significant patient benefit, focusing on areas like immunology, regenerative medicine, and digital health. The fund provides financial support and strategic guidance to portfolio companies.

Founded 2010
Investment Stages
Seed
Series A
Series B
Markets
Immunomodulation
Immuno-Oncology
Tissue Regeneration
New Therapeutic Modalities
Gene Therapy
Cell-based therapeutics
Microbiome
Antiinfectives
Patients Care Management
Digital Health
Breakout Ventures favicon
Breakout Ventures
United States

Breakout Ventures invests in early-stage companies building bio-based solutions to improve human health and sustainability. They support companies from seed to scale, providing resources and a network to help them reach critical milestones. Their focus is on creative bioscience entrepreneurs building the future.

Founded 2016
Investment Stages
Seed
Series A
Series B
Markets
Biotechnology
Life Sciences
Therapeutics
Biomanufacturing
Sustainable Materials
CincyTech favicon
CincyTech
United States

CincyTech is a venture capital firm that invests in innovative founders tackling the world's complex challenges. Their experienced team partners early to help transform ideas into world-class companies.

Founded 2006
Investment Stages
Series A
Series B
Markets
Therapeutics
SaaS
Precision Medicine
Medical Device
Infrastructure
Gene Therapy
FinTech
EdTech
Digital Health
Diagnostics
Data Management
Consumer Digital
Advanced Materials
AdTech
AI / ML
Elm Street Ventures favicon
Elm Street Ventures
United States

Elm Street Ventures is a Yale-focused seed and early-stage venture fund based in New Haven, Connecticut. They invest in companies with a Yale connection, focusing on great people and great science to achieve great impact. Their investments typically range from $500,000 to $1 million initially, with potential for follow-on investments.

Founded 2006
Investment Stages
Seed
Series A
Markets
Life Sciences
Therapeutics
Medical Devices
Diagnostics
Research Tools and Services
Digital Health
Materials
Healthcare
Healthcare Services
Clean Technology
Green Chemistry
Information Technology
Mobile
Social Web
EQT Life Sciences favicon
EQT Life Sciences
Netherlands

EQT Life Sciences, formerly LSP, is one of Europe’s largest and most experienced life sciences investors. They provide capital and strategic support to innovative companies developing therapeutics, medical devices, diagnostics, and healthtech globally. Their focus is on transforming scientific innovation into impactful healthcare solutions.

Founded 1998
Investment Stages
Series A
Series B
Series C
Markets
Therapeutics
Medical Devices
Diagnostics
Healthtech
Biotech
F-Prime Capital favicon
F-Prime Capital
United States, United Kingdom

F-Prime Capital is a venture capital firm investing in healthcare and technology.

Founded 1946
Investment Stages
Seed
Series A
Series B
Markets
Healthcare
Technology
Therapeutics
Medtech
Health IT & Services
Enterprise Software
Fintech
Frontier Tech
Foresite Capital favicon
Foresite Capital
United States

Foresite Capital is a multi-stage healthcare and life sciences investment firm. They use a data science-driven approach to invest in companies leveraging biology and big data to transform healthcare, focusing on opportunities at the intersection of tech and biotech.

Founded 2011
Investment Stages
Series A
Series B
Series C
Markets
Healthcare
Life Sciences
Biotechnology
Therapeutics
Good Growth Capital favicon
Good Growth Capital
United States

Good Growth Capital is an early-stage venture capital firm investing in transformative science and technology. They excel at identifying hidden potential in early-stage tech and provide mentoring to founders. Their investments focus on impact sectors as defined by the UN Sustainable Development Goals.

Founded 2015
Investment Stages
Seed
Series A
Series B
Series C
Markets
Life Sciences
Data Sciences
GreenTech
Medical Devices
Therapeutics
Diagnostics
SaaS
Clean Energy & Efficiency
Battery Tech
Renewables
Advanced Materials
Chemistry & Physics
Consumer
Green Park & Golf Ventures favicon
Green Park & Golf Ventures
United States

Green Park & Golf Ventures is a venture capital firm focused on early-stage investments in medical-related startups. They leverage the extensive operational and financial experience of their founding partners to provide strategic solutions and a strong network to their portfolio companies. Their investments typically range from $500,000 to $2,000,000.

Founded 2011
Investment Stages
Seed
Series A
Series B
Markets
Medical Devices
Therapeutics
Diagnostics
Dental
Consumer Health
Health IT
Tech/SaaS
Hadean Ventures favicon
Hadean Ventures
Norway, Sweden

Hadean Ventures is a European life science venture capital fund manager based in the Nordics. We invest across Europe in companies developing innovative new medical solutions within pharma, biotech, medtech, diagnostics and digital health. Hadean Ventures has offices in Oslo and Stockholm.

Founded 2014
Investment Stages
Series A
Series B
Series C
Markets
Life Science
Healthcare
Biotech
Medical Devices
Digital Therapeutics